NCT00235924|UnknownPhase 3
Loading search results
Sponsor study identifier
interventional
300
0 countries
N/A
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThe main objective of this study is to determine the effects on the endometrium and breast of 70 mg daily dose of isoflavones.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
October 7, 2005
Actual (reported)October 12, 2005
Actual (reported)- Endometrial innocuity (endometrial biopsy result)
- Mammary innocuity (mammography results)
- climacteric symptoms
-Lipid profile
-gynaecological and general safety
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pierre MARES, Professor
Hospital of Caremeau, Nîmes, FRANCE
Santiago PALACIOS, Professor
Instituto Palacios, Madrid, SPAIN
Bruno PORNEL, Doctor
Brussels Menopause Center, Bruxelles, BELGIUM
John EDEN, Professor
Sydney Menopause Center, Sydney, AUSTRALIA
First Submitted
October 7, 2005
First Posted
October 12, 2005
Study Start
June 2004
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
December 8, 2005
Record last verified: 2005-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
Contact the study team to confirm eligibility.